Table 3.
Final Visual Acuity
| Total | ≥20/40 | 20/50–5/200 | <5/200 | Total | |
|---|---|---|---|---|---|
| 49 (79.0) | 7 (11.3) | 6 (9.7) | 62 (100) | ||
| VA at presentation | LP | 10 (55.5) | 6 (33.3) | 2 (11.1) | 18 |
| >LP | 39 (88.6) | 1 (2.3) | 4 (9.1) | 44 | |
| HM | 20 (87.0) | 1 (4.3) | 2 (8.7) | 23 | |
| CF | 8 (80.0) | 0 (0.0) | 2 (20.0) | 10 | |
| >5/200 | 11 (100.0) | 0 (0.0) | 0 (0.0) | 11 | |
| Initial treatment | VIT | 36 (75.0) | 6 (12.5) | 6 (12.5) | 48 |
| TAP | 13 (92.9) | 1 (7.1) | 0 (0.0) | 14 | |
| Organism | Virulent | 10 (52.6) | 4 (21.0) | 5 (26.3) | 19a |
| Negative or Non-Virulent | 39 (90.7) | 3 (7.0) | 1 (2.3) | 43 | |
| Days from CEIOL to presentation | <5 days | 28 (90.3) | 2 (6.4) | 1 (3.2) | 31 |
| ≥5 days | 21 (67.7) | 5 (16.1) | 5 (16.1) | 31 | |
Notes: aIncludes a patient that grew Staphylococcus coagulase-negative on first culture but Streptococcus on second culture.
Abbreviations: VA, visual acuity; LP, light perception; HM, hand motion; CF, counting fingers; VIT, vitrectomy; TAP, tap-and-inject; CEIOL, cataract extraction with intraocular lens implantation.